Omidria 1-0.3% vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FH5DU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,783
Award facts
- Contract value 100% obligated
- $4,783.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4.78K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Omidria 1-0.3% vials (4mL). The delivery order was issued on August 25, 2025, with an ultimate completion date of September 16, 2025, under a firm fixed-price contract structure. This award represents a discrete task order issued against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499.999 billion and valid through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to secure contracts without set-aside designations. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This particular delivery order for Omidria, an ophthalmic pharmaceutical used during cataract surgery, exemplifies the company's portfolio of specialized medical products supporting Department of Defense healthcare operations. The award carries no set-aside designation and reflects the vendor's consistent performance as a sole-source distributor through the DLA's primary pharmaceutical supply contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FH5DU?
SPE2DB25FH5DU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FH5DU worth?
The government has obligated $4,783 on SPE2DB25FH5DU.
Is contract SPE2DB25FH5DU an order under another contract?
Yes. SPE2DB25FH5DU is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5DU competed?
The extent of competition for SPE2DB25FH5DU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award